Save your place

Sign in to WhoBought

Please try again later.

Seth Klarman's Vaxcyte, Inc. (PCVX) position

Yes: as of Q1 2026, Seth Klarman holds 800K shares of PCVX worth $46M (0.9% of the disclosed portfolio). Last quarter the position was opened. First disclosed Q1 2026.
View full portfolio →
Current value
$46M
Shares held
800K
% of portfolio
0.9%
Est. average buy price (i)
$54.29
Quarter-end price
$58.11

Estimated trade prices

Average price in quarters with purchases
$54.29

PCVX price vs Klarman's position

Dates
$10$50$100$15020222023202420252026New position of 800K shares · Q1 2026. Average closing price $54.29 · Price range $44.85–$63.04800Ksharespurchased
Average closing price · filing quarter
$54.29
Price range · filing quarter
$44.85 – $63.04

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 New +800K +$43M 800K May 14, 2026
Data through Q1 2026 · filed May 14, 2026
1 grouped rows from 1 quarters

More Klarman positions

Common questions

Does Seth Klarman own PCVX?

Yes. As of Q1 2026, Seth Klarman disclosed 800K shares of PCVX, worth $46M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Seth Klarman buy PCVX?

Seth Klarman first disclosed a PCVX position in Q1 2026; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Seth Klarman sell PCVX?

The quarter-by-quarter table above shows each sale and reduction Seth Klarman disclosed in PCVX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of PCVX does Seth Klarman own?

Seth Klarman disclosed 800K shares of PCVX as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Seth Klarman pay for PCVX?

Seth Klarman's estimated average buy price for PCVX is $54.29, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.